Relation of cytokines to vasodilation after coronary artery bypass grafting

World Journal of Surgery

Volumn 27, Issue 10, 2003, Pages 1093-1098

  Wei, Minxin ^a   Kuukasjärvi, Pekka ^a   Laurikka, Jari ^a   Kaukinen, Seppo ^b   Honkonen, Eva Liisa ^b   Metsänoja, Riina ^c   Tarkka, Matti ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN DERIVATIVE; NORADRENALIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY SURGERY; CORONARY HEMODYNAMICS; CYTOKINE PRODUCTION; HEART MUSCLE REPERFUSION; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RISK FACTOR; VASODILATATION;

AGED; CARDIOPULMONARY BYPASS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASODILATION;

EID: 0141958028     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-6934-7     Document Type: Article

References (25)

1. Jansen NJ, van Oeveren W, Gu YJ, et al. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann. Thorac. Surg. 1992;54:744-748
2. Haeffner-Cavaillon N, Roussellier N, Ponzio O, et al. Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 1989;98:1100-1106
3. Wei M, Kuukasjärvi P, Laurikka J, et al. Cytokine responses in low-risk CABG. Int. J. Angiol. 2001;10:27-30
4. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J. Thorac. Cardiovasc. Surg. 1994;108:626-635
5. Vallely MP, Bannon PG, Kritharides L. The systemic inflammatory response syndrome and off-pump cardiac surgery. Heart Surg. Forum 2001;4:S7-S13
6. Bernard C, Tedgui A. Cytokine network and the vessel wall: insights into septic shock pathogenesis. Eur. Cytokine Netw. 1992;3:19-33
7. Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann. Thorac. Surg. 1996;61:1714-1720
8. Menasche P, Haydar S, Peynet J, et al. A potential mechanism of vasodilation after warm heart surgery: the temperature-dependent release of cytokines. J. Thorac. Cardiovasc. Surg. 1994;107:293-299
9. Wei M, Kuukasjärvi P, Laurikka J, et al. Cytokine responses and myocardial injury in coronary artery bypass grafting. Scand. J. Clin. Lab. Invest. 2001;61:161-166
10. Wan S, LeClerc JL, Vincent JL. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann. Thorac. Surg. 1997;63:269-276
11. Sakai T, Latson TW, Whitten CW, et al. Perioperative measurements of IL-6 and alpha-melanocyte-stimulating hormone in cardiac transplant patients. J. Cardiothorac. Vasc. Anesth. 1993;7:17-22
12. Sawa Y, Ichikawa H, Kagisaki K, et al. IL-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium. J. Thorac. Cardiovasc. Surg. 1998;116:511-517
13. Finn A, Naik S, Klein N, et al. IL-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 1993;105:234-241
14. Rollins BJ. Chemokines. Blood 1997;90:909-928
15. Leeuwenberg JF, Jeunhomme TM, Buurman WA. Slow release of soluble TNF receptors by monocytes in vitro. J. Immunol. 1994;152:4036-4043
16. Te Velthuis H, Jansen PG, Oudemans-van Straaten HM, et al. Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor. J. Thorac. Cardiovasc. Surg. 1995;110:1663-1669
17. Deng MC, Dasch B, Erren M, et al. Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting. Ann. Thorac. Surg. 1996;62:184-190
18. Christakis GT, Fremes SE, Koch JP, et al. Determinants of low systemic vascular resistance during cardiopulmonary bypass. Ann. Thorac. Surg. 1994;58:1040-1049
19. Wei M, Kuukasjärvi P, Laurikka J, et al. Inflammatory cytokines and soluble receptors after coronary artery bypass grafting. Cytokine 2001;15:223-228
20. Liebold A, Keyl C, Birnbaum DE. The heart produces but the lungs consume proinflammatory cytokines following cardiopulmonary bypass. Eur. J. Cardiothorac. Surg. 1999;15:340-345
21. Wan S, DeSmet JM, Barvais L, et al. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 1996;112:806-811
22. Goldblum SE, Cohen DA, Gillespie MN, et al. Interleukin-1-induced granulocytopenia and pulmonary leukostasis in rabbits. J. Appl. Physiol. 1987;62:122-128
23. Entman ML, Michael L, Rossen RD, et al. Inflammation in the course of early myocardial ischemia. FASEB J. 1991;5:2529-2537
24. Kawamura T, Inada K, Okada H, et al. Methylprednisolone inhibits increase of interleukin 8 and 6 during open heart surgery. Can. J. Anaesth. 1995;42:399-403
25. Diego RP, Mihalakakos PJ, Hexum TD, et al. Methylprednisolone and full-dose aprotinin reduce reperfusion injury after cardiopulmonary bypass. J. Cardiothorac. Vasc. Anesth. 1997;11:29-31